Safety outcomes of direct oral anticoagulants in older adults with atrial fibrillation: a systematic review and meta-analysis of (subgroup analyses from) randomized controlled trials. | 2024 | GeroScience |
Safety and efficacy of direct oral anticoagulants in comparison to warfarin in obese patients with atrial fibrillation: a systematic review and meta-analysis. | 2024 | Health Science Reports |
Comparing anticoagulation strategies for venous thromboembolism associated with active cancer: a systematic review and meta-analysis. | 2024 | JACC. CardioOncology. |
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis. | 2023 | The Cochrane Database of Systematic Reviews |
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism. | 2023 | The Cochrane Database of Systematic Reviews |
Effectiveness and safety of edoxaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies. | 2023 | Frontiers in Pharmacology |
The effectiveness and safety of direct oral anticoagulants compared to conventional pharmacologic thromboprophylaxis in hip fracture patients: a systematic review and meta-analysis of randomized controlled trials. | 2023 | Orthopaedics & Traumatology, Surgery & Research |
Efficacy and safety of direct oral anticoagulants for stroke prevention in older patients with atrial fibrillation: a network meta-analysis of randomized controlled trials. | 2023 | Journal of the American Heart Association |
Severe bleeding risk of direct oral anticoagulants versus Vitamin K antagonists for stroke prevention and treatment in patients with atrial fibrillation: a systematic review and network meta-analysis. | 2023 | Cardiovascular Drugs and Therapy |
Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials. | 2023 | European Heart Journal Cardiovascular Pharmacotherapy |
Efficacy and safety of renal function on edoxaban versus warfarin for atrial fibrillation: a systematic review and meta-analysis. | 2023 | Medicines |
Direct oral anticoagulation in atrial fibrillation and heart valve surgery-a meta-analysis and systematic review. | 2022 | Therapeutic Advances in Cardiovascular Disease |
Direct oral anticoagulants compared with dalteparin for treatment of cancer-associated thrombosis: a living, interactive systematic review and network meta-analysis. | 2022 | Mayo Clinic Proceedings |
Short-term efficacy and safety of edoxaban for venous thromboembolism after total hip or knee arthroplasty: a systematic review and meta-analysis. | 2022 | European Review for Medical and Pharmacological Sciences |
Optimal stroke preventive strategy for patients aged 80 years or older with atrial fibrillation: a systematic review with traditional and network meta-analysis. | 2022 | Age and Ageing |
Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis. | 2022 | Future Cardiology |
A network meta-analysis of direct factor Xa inhibitors for the treatment of cancer-associated venous thromboembolism. | 2022 | Vascular |
The use of non-vitamin K oral anticoagulants in dialysis patients—A systematic review. | 2022 | Seminars in Dialysis |
Oral anticoagulant agents in patients with atrial fibrillation and CKD: a systematic review and pairwise network meta-analysis. | 2021 | American Journal of Kidney Disease |
A network meta-analysis of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and diabetes mellitus. | 2021 | Acta Cardiologica |
The association of fracture risk in atrial fibrillation patients and long-term anticoagulant therapy category: a systematic review and meta-analysis. | 2021 | PeerJ |
Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials. | 2021 | Journal of Neurology |
Major gastrointestinal bleeding risk with direct oral anticoagulants: Does type and dose matter? - A systematic review and network meta-analysis. | 2021 | European Journal of Gastroenterology & Hepatology |
Ranking the efficacy of anticoagulants for the prevention of venous thromboembolism after total hip or knee arthroplasty: a systematic review and a network meta-analysis. | 2021 | Pharmacological Research |
Oral anticoagulant agents in patients with atrial fibrillation and CKD: a systematic review and pairwise network meta-analysis. | 2021 | American Journal of Kidney Diseases |
The risk of gastrointestinal bleeding between non-vitamin K antagonist oral anticoagulants and vitamin K antagonists in the Asian atrial fibrillation patients: a meta-analysis. | 2021 | International Journal of Environmental Research and Public Health |
The risk of gastrointestinal hemorrhage with non-vitamin K antagonist oral anticoagulants: a network meta-analysis. | 2021 | Medicine |
A network meta-analysis comparing osteoporotic fracture among different direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation. | 2021 | Journal of Bone Metabolism |
Pharmacogenetics of direct oral anticoagulants: a systematic review. | 2021 | Journal of Personalized Medicine |
Efficacy and safety of anticoagulants for postoperative thromboprophylaxis in total hip and knee arthroplasty: a PRISMA-compliant Bayesian network meta-analysis. | 2021 | PLoS One |
The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: a systematic review and meta-analysis. | 2021 | The Anatolian Journal of Cardiology |
Reappraisal of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: a systematic review and meta-analysis. | 2021 | Frontiers in Cardiovascular Medicine |
Comparative efficacy and safety of warfarin care bundles and novel oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis. | 2020 | Scientific Reports |
Non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: evidences from the real-world data. | 2020 | Heart Failure Reviews |
Direct oral anticoagulants for the treatment of acute venous thromboembolism associated with cancer: a systematic review and meta-analysis. | 2020 | Thrombosis and Haemostasis |
Safety and efficacy of oral anticoagulant therapies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis. | 2020 | Journal of Cardiovascular Pharmacology and Therapeutics |
Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: a systematic review with meta-analysis and trial sequential analysis. | 2019 | Archives of Gerontology and Geriatrics |
Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis. | 2019 | Journal of Thrombosis and Haemostasis |
Non-vitamin K oral anticoagulants in nonvalvular atrial fibrillation: a network meta-analysis. | 2019 | Scandinavian Cardiovascular Journal |
Causes of death in patients with venous thromboembolism anticoagulated with direct oral anticoagulants: a systematic review and meta-analysis. | 2018 | Seminars in Thrombosis and Hemostasis |